BridgeBio Pharma (BBIO) Q1 2025 Earnings

20FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.4
-1
-0.6
-0.2

Details

Expected EPS
-1.120162
Actual EPS
-1.4
Surprise EPS
-0.28
Surprise Percent
+24.98%

Description

BridgeBio Pharma (BBIO) has reported earnings of -1.4 per share for Q1 2025.

0 Comments

Share your thoughts